Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus

Tuberculosis (TB) is caused by the bacterial pathogen Mycobacterium tuberculosis (MTB) and is one of the principal reasons for mortality and morbidity worldwide. Currently, recommended anti-tuberculosis drugs include isoniazid, rifampicin, ethambutol, and pyrazinamide. TB treatment is lengthy and in...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Li Zhao, Ke Fan, Xuezhi Sun, Wei Li, Fenfen Qin, Liwen Shi, Feng Gao, Chunlan Zheng
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2024-01-01
סדרה:	Frontiers in Immunology
נושאים:	mycobacterium tuberculosis diabetes mellitus host-directed therapy drug-resistance immune
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1305325/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!